Loading
Proposed US legislation restricting federally funded work with certain Chinese biotech service companies, which would affect where ADCs and sequencing get done.
The BIOSECURE Act is proposed US legislation that would restrict federally funded work with certain Chinese biotechnology service companies, affecting where ADCs are made and where sequencing is done. It passed the House in 2024 and was reintroduced in 2025, naming WuXi AppTec, WuXi Biologics, BGI, MGI and Complete Genomics, and sponsors are already diversifying their CDMO and sequencing supply in anticipation. Its status should be verified before it is cited as law. The term is linked to the companies WuXi XDC and MGI Tech, to the technologies ADC bioconjugation manufacturing (CDMOs) and New short-read sequencing platforms, and to the related term CDMO (contract development and manufacturing organisation), each of which references it in turn.
Showing the technology this term belongs to: ADC bioconjugation manufacturing (CDMOs).
Shares PIPL (China Personal Information Protection Law 2021), China Human Genetic Resources rules (2019, 2023).
Shares PIPL (China Personal Information Protection Law 2021), China Human Genetic Resources rules (2019, 2023).
Shares CDMO (contract development and manufacturing organisation), ADC bioconjugation manufacturing (CDMOs).
Shares PIPL (China Personal Information Protection Law 2021), China Human Genetic Resources rules (2019, 2023).
Shares PIPL (China Personal Information Protection Law 2021), China Human Genetic Resources rules (2019, 2023).
Shares PIPL (China Personal Information Protection Law 2021), China Human Genetic Resources rules (2019, 2023).